Human PSC-Derived SAN-Plexus Assembloids: A Human Model for Pacemaker Maturation and Neuro-Cardiac Crosstalk

Study Background and Research Question

The sinoatrial node (SAN) is the heart's primary pacemaker, orchestrating rhythmic electrical impulses that initiate each heartbeat. Its function is tightly regulated by intrinsic neural circuits, particularly the cardiac ganglionated plexus, which modulates heart rate and pacemaker site dominance. While the developmental and physiological principles of SAN function have been explored in animal models, significant interspecies differences and limited availability of human SAN tissue have hampered progress in understanding human-specific mechanisms. Moreover, existing human pluripotent stem cell (hPSC) models and cardiac organoids typically lack the three-dimensional organization and autonomic innervation necessary to recapitulate neuro-cardiac interactions or model conduction disorders relevant to human disease. This gap has constrained both basic research and translational efforts targeting arrhythmias and congenital SAN dysfunction.

Key Innovation from the Reference Study

The reference study presents a pioneering approach by generating human SAN-plexus assembloids that integrate three distinct organoid types: SAN organoids (SANOs), cardiac ganglionated plexus organoids (CGPOs), and atrial-like cardiac organoids. This tri-assembloid system models not only the intrinsic pacemaker activity of the SAN but also its electrical coupling with the atria and modulation by neural inputs. By leveraging spatial transcriptomics and functional electrophysiological assays, the study uncovers a neuron-to-pacemaker signaling axis—specifically, CGPO-derived prosaposin engaging the SAN-enriched receptor GPR37—that promotes pacemaker maturation. This innovation establishes a fully human in vitro platform for dissecting the developmental and disease mechanisms underlying SAN maturation and neuro-cardiac crosstalk.

Methods and Experimental Design Insights

The study's experimental framework centers on the co-differentiation and assembly of hPSC-derived cellular components:

• SAN organoids (SANOs): Generated from hPSC populations enriched for TBX18+ and ISL1+ progenitors, resembling the head, tail, and transitional cell subtypes of the human SAN.
• Cardiac ganglionated plexus organoids (CGPOs): Derived to recapitulate the neuronal populations innervating the SAN, with a focus on autonomic (parasympathetic) neuron identity.
• Atrial cardiac organoids: Provide a substrate for pacemaker-to-atrial conduction studies, enabling the modeling of impulse propagation.

These organoids are integrated into a three-dimensional tri-assembloid, recapitulating the spatial architecture of the human SAN-cardiac plexus-atrial interface. Spatial transcriptomics is employed to map gene expression patterns, aligning the in vitro system with anatomical features of the human SAN. Electrophysiological analyses—including voltage-sensitive dye imaging and patch-clamp techniques—interrogate spontaneous activity, conduction velocity, and response to neural modulation. The platform also allows for functional manipulation of specific neuron-to-pacemaker signaling pathways, facilitating mechanistic dissection of neuro-cardiac regulation.

Core Findings and Why They Matter

The SAN-plexus assembloid model demonstrates several key properties:

• Molecular and functional recapitulation: The assembloids express hallmark transcriptional regulators (e.g., SHOX2, ISL1, TBX3) and ion channels (e.g., HCN4) characteristic of human SAN tissue. Electrophysiological profiling reveals spontaneous diastolic depolarization and slow action potentials typical of pacemaker cells, as well as effective conduction to atrial organoids.
• Neural modulation of pacemaker activity: Integration of CGPOs enables functional interrogation of autonomic influences on SAN activity, including modulation of firing rate and leading pacemaker site. Notably, the model recapitulates disease-relevant conduction dysfunctions seen in congenital SAN disorders.
• Discovery of neuron-to-pacemaker maturation signals: By combining spatial transcriptomics with functional analysis, the study identifies a CGPO-derived prosaposin–GPR37 axis that promotes SAN maturation, highlighting a previously unappreciated mechanism of neuro-cardiac crosstalk in human development.

These findings provide a robust, human-specific platform for exploring the molecular and physiological underpinnings of pacemaker development, conduction disorders, and autonomic regulation—areas where traditional animal models have proven insufficient.

Comparison with Existing Internal Articles

Several internal resources have discussed related advances and experimental workflows. For example, "Modeling Human SAN-Plexus Interactions with PSC-Derived Assembloids" and "Modeling Human SAN-Plexus Interactions via PSC-Derived Assembloids" both overview the development of human in vitro platforms for studying SAN-neural interactions, echoing the reference study's emphasis on cellular heterogeneity and functional innervation. These reviews contextualize the technical leap provided by integrating spatial transcriptomics and functional assays in a tri-assembloid system, as achieved in the current study.

More practically, articles such as "Isoproterenol Sulfate Dihydrate: Advancing Human Pacemaker Models" and "Isoproterenol Sulfate Dihydrate in Human Pacemaker Assays" detail protocols for interrogating beta-adrenergic receptor signaling in assembloid systems. These resources illustrate how high-purity agonists such as Isoproterenol sulfate dihydrate enable reproducible stimulation of the cAMP/PKA pathway, supporting the functional readouts central to SAN-neural research.

Limitations and Transferability

While the SAN-plexus assembloid model represents a significant methodological advance, certain limitations merit consideration:

• Developmental maturity: Although the assembloids display key markers and functional properties of human SAN tissue, the degree to which these systems recapitulate the full electrophysiological and structural maturity of adult pacemaker complexes remains to be comprehensively validated.
• Model complexity and scalability: The tri-assembloid assembly and spatial transcriptomic mapping require specialized expertise and resources, which may limit widespread adoption or scalability for high-throughput applications.
• Translational relevance: Despite improved fidelity relative to animal models, extrapolation to in vivo human physiology is constrained by the absence of systemic factors, including circulating hormones and long-range autonomic inputs.

Nevertheless, the system is highly transferable for dissecting human-specific GPCR signaling, neuro-cardiac crosstalk, and mechanisms underlying conduction system diseases—especially in the context of genetic perturbations or pharmacological modulation.

Protocol Parameters

• SAN/CGPO co-culture duration: 7–14 days to allow for synaptic integration and stable neural modulation of pacemaker activity, as supported by the reference system.
• Electrophysiological monitoring: Use voltage-sensitive dye imaging or whole-cell patch clamp to assess diastolic depolarization and conduction velocity in SAN-plexus assembloids.
• Beta-adrenergic stimulation: Suggested concentration ranges for Isoproterenol hemisulfate (e.g., 10 nM–1 µM) should be optimized per assay, referencing established protocols in recent internal workflows.
• Spatial transcriptomics: Perform on assembloids after 10–14 days of co-culture to capture neuron-pacemaker signaling signatures aligned with human SAN tissue maps.

Research Support Resources

To enable rigorous modeling of human beta-adrenergic receptor signaling and validate GPCR/cAMP/PKA pathway modulation in assembloid workflows, researchers may incorporate Isoproterenol sulfate dihydrate (SKU C6402). This high-purity, water-soluble Isoproterenol hemisulfate is specifically formulated for research use in cardiovascular and neuro-cardiac systems. For detailed application guidance—including storage, solubility, and protocol optimization—users should consult the product information and relevant methodological articles. APExBIO supplies this reagent in forms compatible with advanced human cell and organoid models, facilitating reproducible interrogation of beta-adrenergic signaling in SAN-plexus assembloid studies.